Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TBio-4101 |
Trade Name | |
Synonyms | TBio4101|TBio 4101 |
Drug Descriptions |
TBio-4101 are tumor-derived autologous tumor infiltrating lymphocytes (TILs), which may induce killing of tumor cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C191762 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + TBio-4101 | Pembrolizumab TBio-4101 | 0 | 1 |
TBio-4101 | TBio-4101 | 0 | 2 |